{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T08:14:05Z","timestamp":1794039245437,"version":"4.8.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T00:00:00Z","timestamp":1764028800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T00:00:00Z","timestamp":1764028800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"This study was supported by the institutional foundation of the First Affiliated Hospital of Xi'an Jiaotong University","award":["2024-QN-39"],"award-info":[{"award-number":["2024-QN-39"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Equity Health"],"DOI":"10.1186\/s12939-025-02691-0","type":"journal-article","created":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T12:21:16Z","timestamp":1764073276000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Global burden of leishmaniasis, 1990\u20132021: systematic analysis of the global burden of disease study"],"prefix":"10.1186","volume":"24","author":[{"given":"Sijia","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tongtong","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaqin","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miaoyin","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,25]]},"reference":[{"key":"2691_CR1","doi-asserted-by":"crossref","unstructured":"Lin Y, Fang K, Zheng Y, Wang HL, Wu J. Global burden and trends of neglected tropical diseases from 1990 to 2019. J Travel Med. 2022;29.","DOI":"10.1093\/jtm\/taac031"},{"key":"2691_CR2","doi-asserted-by":"crossref","unstructured":"Xiang Q, Li T, He M, Zhang S, Luo Y, Zou J, Li G, Su Q, He S, Yu W, Gu D. Global Infectious Diseases in December 2022: Monthly Analysis. Zoonoses. 2023;3.","DOI":"10.15212\/ZOONOSES-2022-1005"},{"key":"2691_CR3","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1016\/j.jaad.2014.08.051","volume":"73","author":"MZ Handler","year":"2015","unstructured":"Handler MZ, Patel PA, Kapila R, Al-Qubati Y, Schwartz RA. Cutaneous and mucocutaneous leishmaniasis: clinical perspectives. J Am Acad Dermatol. 2015;73:897\u2013908. quiz 909\u2009\u2013\u2009810.","journal-title":"J Am Acad Dermatol"},{"key":"2691_CR4","doi-asserted-by":"publisher","first-page":"e1326","DOI":"10.1111\/tbed.14660","volume":"69","author":"JA Mendoza-Roldan","year":"2022","unstructured":"Mendoza-Roldan JA, Votypka J, Bandi C, Epis S, Modry D, Ticha L, Volf P, Otranto D. Leishmania tarentolae: A new frontier in the epidemiology and control of the leishmaniases. Transbound Emerg Dis. 2022;69:e1326\u201337.","journal-title":"Transbound Emerg Dis"},{"key":"2691_CR5","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/S0140-6736(18)31204-2","volume":"392","author":"S Burza","year":"2018","unstructured":"Burza S, Croft SL, Boelaert M. Leishmaniasis. Lancet. 2018;392:951\u201370.","journal-title":"Lancet"},{"key":"2691_CR6","unstructured":"Leishmaniasis. [https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/leishmaniasis]."},{"key":"2691_CR7","doi-asserted-by":"publisher","first-page":"e0006250","DOI":"10.1371\/journal.pntd.0006250","volume":"12","author":"EJ Lenk","year":"2018","unstructured":"Lenk EJ, Redekop WK, Luyendijk M, Fitzpatrick C, Niessen L, Stolk WA, Tediosi F, Rijnsburger AJ, Bakker R, Hontelez JAC, et al. Socioeconomic benefit to individuals of achieving 2020 targets for four neglected tropical diseases controlled\/eliminated by innovative and intensified disease management: human African trypanosomiasis, leprosy, visceral leishmaniasis, Chagas disease. PLoS Negl Trop Dis. 2018;12:e0006250.","journal-title":"PLoS Negl Trop Dis"},{"key":"2691_CR8","first-page":"e25698","volume":"14","author":"F Pasha","year":"2022","unstructured":"Pasha F, Saleem S, Nazir T, Tariq J, Qureshi K. Visceral leishmaniasis (Kala-Azar): A triumph against a trickster disease. Cureus. 2022;14:e25698.","journal-title":"Cureus"},{"key":"2691_CR9","doi-asserted-by":"crossref","unstructured":"Wu X, Wen X, Song S, Zhao C, Shao Z, Liu K, Fu T. Global distribution and prediction of transmission-risk of visceral leishmaniasis. Zoonoses. 2024;4.","DOI":"10.15212\/ZOONOSES-2023-0059"},{"key":"2691_CR10","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1007\/s40121-022-00602-2","volume":"11","author":"RK Madusanka","year":"2022","unstructured":"Madusanka RK, Silva H, Karunaweera ND. Treatment of cutaneous leishmaniasis and insights into Species-Specific responses: A narrative review. Infect Dis Ther. 2022;11:695\u2013711.","journal-title":"Infect Dis Ther"},{"key":"2691_CR11","first-page":"763","volume":"22","author":"T Fischer","year":"2024","unstructured":"Fischer T, Fischer M, Schliemann S, Elsner P. Treatment of mucocutaneous leishmaniasis - A systematic review. J Dtsch Dermatol Ges. 2024;22:763\u201373.","journal-title":"J Dtsch Dermatol Ges"},{"key":"2691_CR12","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1038\/s41591-022-01990-1","volume":"28","author":"CJL Murray","year":"2022","unstructured":"Murray CJL. The global burden of disease study at 30 years. Nat Med. 2022;28:2019\u201326.","journal-title":"Nat Med"},{"key":"2691_CR13","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1016\/S0140-6736(24)00757-8","volume":"403","author":"GBD Diseases","year":"2024","unstructured":"Diseases GBD, Injuries C. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990\u20132021: a systematic analysis for the global burden of disease study 2021. Lancet. 2024;403:2133\u201361.","journal-title":"Lancet"},{"key":"2691_CR14","doi-asserted-by":"publisher","first-page":"2259","DOI":"10.1016\/S0140-6736(24)00769-4","volume":"403","author":"CJL Murray","year":"2024","unstructured":"Murray CJL, Collaborators GBD. Findings from the global burden of disease study 2021. Lancet. 2024;403:2259\u201362.","journal-title":"Lancet"},{"key":"2691_CR15","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.1016\/S0140-6736(24)00933-4","volume":"403","author":"GBDRF Collaborators","year":"2024","unstructured":"Collaborators GBDRF. Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990\u20132021: a systematic analysis for the global burden of disease study 2021. Lancet. 2024;403:2162\u2013203.","journal-title":"Lancet"},{"key":"2691_CR16","unstructured":"Results from the. 2021 Global Burden of Disease (GBD) study [https:\/\/ghdx.healthdata.org\/gbd-results-tool]"},{"key":"2691_CR17","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1016\/S0140-6736(16)31012-1","volume":"388","author":"GBD Mortality","year":"2016","unstructured":"Mortality GBD, Causes of Death C. Global, regional, and National life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980\u20132015: a systematic analysis for the global burden of disease study 2015. Lancet. 2016;388:1459\u2013544.","journal-title":"Lancet"},{"key":"2691_CR18","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1177\/003335491212700309","volume":"127","author":"Y Jiang","year":"2012","unstructured":"Jiang Y, Hesser JE. Using disability-adjusted life years to assess the burden of disease and injury in Rhode Island. Public Health Rep. 2012;127:293\u2013303.","journal-title":"Public Health Rep"},{"key":"2691_CR19","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1186\/s12889-022-14042-7","volume":"22","author":"SS Cohen","year":"2022","unstructured":"Cohen SS, Bylsma LC, Movva N, Alexander DD. Theoretical attributable risk analysis and disability adjusted life years (DALYs) based on increased dairy consumption. BMC Public Health. 2022;22:1625.","journal-title":"BMC Public Health"},{"key":"2691_CR20","doi-asserted-by":"publisher","first-page":"e0292723","DOI":"10.1371\/journal.pone.0292723","volume":"18","author":"O Dutta","year":"2023","unstructured":"Dutta O, Prasanth A, Kumari A, Akanksha K, Deeba F, Salam N. Burden of dengue, leishmaniasis and lymphatic filariasis in India and its States from 1990\u20132019: analysis from the global burden of disease study (GBD 2019). PLoS ONE. 2023;18:e0292723.","journal-title":"PLoS ONE"},{"key":"2691_CR21","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1016\/j.jaad.2020.08.043","volume":"84","author":"CJ Scheufele","year":"2021","unstructured":"Scheufele CJ, Giesey RL, Delost GR. The global, regional, and National burden of leishmaniasis: an Ecologic analysis from the global burden of disease study 1990\u20132017. J Am Acad Dermatol. 2021;84:1203\u20135.","journal-title":"J Am Acad Dermatol"},{"key":"2691_CR22","doi-asserted-by":"publisher","first-page":"e35671","DOI":"10.1371\/journal.pone.0035671","volume":"7","author":"J Alvar","year":"2012","unstructured":"Alvar J, Velez ID, Bern C, Herrero M, Desjeux P, Cano J, Jannin J, den Boer M, Team WHOLC. Leishmaniasis worldwide and global estimates of its incidence. PLoS ONE. 2012;7:e35671.","journal-title":"PLoS ONE"},{"key":"2691_CR23","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s40475-021-00232-7","volume":"8","author":"S Mann","year":"2021","unstructured":"Mann S, Frasca K, Scherrer S, Henao-Martinez AF, Newman S, Ramanan P, Suarez JA. A review of leishmaniasis: current knowledge and future directions. Curr Trop Med Rep. 2021;8:121\u201332.","journal-title":"Curr Trop Med Rep"},{"key":"2691_CR24","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1186\/s12879-019-4353-0","volume":"19","author":"G Herrera","year":"2019","unstructured":"Herrera G, Castillo A, Ayala MS, Florez C, Cantillo-Barraza O, Ramirez JD. Evaluation of four rapid diagnostic tests for canine and human visceral leishmaniasis in Colombia. BMC Infect Dis. 2019;19:747.","journal-title":"BMC Infect Dis"},{"key":"2691_CR25","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s40249-018-0474-8","volume":"7","author":"L Osorio","year":"2018","unstructured":"Osorio L, Garcia JA, Parra LG, Garcia V, Torres L, Degroote S, Ridde V. A scoping review on the field validation and implementation of rapid diagnostic tests for vector-borne and other infectious diseases of poverty in urban areas. Infect Dis Poverty. 2018;7:87.","journal-title":"Infect Dis Poverty"},{"key":"2691_CR26","doi-asserted-by":"publisher","first-page":"e0006697","DOI":"10.1371\/journal.pntd.0006697","volume":"12","author":"JMT Bezerra","year":"2018","unstructured":"Bezerra JMT, de Araujo VEM, Barbosa DS, Martins-Melo FR, Werneck GL, Carneiro M. Burden of leishmaniasis in Brazil and federated units, 1990\u20132016: findings from global burden of disease study 2016. PLoS Negl Trop Dis. 2018;12:e0006697.","journal-title":"PLoS Negl Trop Dis"},{"key":"2691_CR27","doi-asserted-by":"publisher","first-page":"744163","DOI":"10.3389\/fcimb.2021.744163","volume":"11","author":"DH Barroso","year":"2021","unstructured":"Barroso DH, Nobrega OT, de Araujo CN, Freire GSM, Martins SS, Rodrigues BC, Gomes CM, Sampaio RNR. The presence of leishmania Braziliensis DNA in the nasal mucosa of cutaneous leishmaniasis patients and the search for possible clinical and immunological patterns of disease progression: A cross sectional study. Front Cell Infect Microbiol. 2021;11:744163.","journal-title":"Front Cell Infect Microbiol"},{"key":"2691_CR28","doi-asserted-by":"publisher","first-page":"305","DOI":"10.5662\/wjm.v12.i4.305","volume":"12","author":"M Ahmed","year":"2022","unstructured":"Ahmed M, Abdulslam Abdullah A, Bello I, Hamad S, Bashir A. Prevalence of human leishmaniasis in sudan: A systematic review and meta-analysis. World J Methodol. 2022;12:305\u201318.","journal-title":"World J Methodol"},{"key":"2691_CR29","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.puhe.2024.06.003","volume":"234","author":"R Vieira-Duarte","year":"2024","unstructured":"Vieira-Duarte R, Araujo VEM, Veloso GA, Cardoso DT, Ker FTO, Barbosa DS, Malta DC, Nagavi M, Carneiro M, Coura-Vital W. Mortality due to visceral leishmaniasis in Brazil by municipalities, 2001\u20132018: a spatial-temporal analysis of estimates from the global burden of disease study. Public Health. 2024;234:58\u201363.","journal-title":"Public Health"},{"key":"2691_CR30","doi-asserted-by":"publisher","first-page":"102823","DOI":"10.1016\/j.tmaid.2025.102823","volume":"64","author":"G Guido","year":"2025","unstructured":"Guido G, Frallonardo L, Cotugno S, De Vita E, Patti G, De Santis L, Segala FV, Nicastri E, Gobbi F, Morea A, et al. Prevalence of neglected tropical diseases among migrants living in europe: A systematic review and meta-analysis. Travel Med Infect Dis. 2025;64:102823.","journal-title":"Travel Med Infect Dis"},{"key":"2691_CR31","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/j.apjtm.2016.06.021","volume":"9","author":"A Oryan","year":"2016","unstructured":"Oryan A, Akbari M. Worldwide risk factors in leishmaniasis. Asian Pac J Trop Med. 2016;9:925\u201332.","journal-title":"Asian Pac J Trop Med"},{"key":"2691_CR32","doi-asserted-by":"publisher","first-page":"e08002020","DOI":"10.1590\/0037-8682-0800-2020","volume":"54","author":"M Monteiro","year":"2021","unstructured":"Monteiro M, Silva M, Paiva AA, Marreiro DDN, Luzia LA, Henriques GS, Rondo PHC, Sene IS, Almeida ATA, Costa CHN, Costa DL. Nutritional status and vitamin A and zinc levels in patients with kala-azar in Piaui, Brazil. Rev Soc Bras Med Trop. 2021;54:e08002020.","journal-title":"Rev Soc Bras Med Trop"},{"key":"2691_CR33","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1111\/tmi.12877","volume":"22","author":"DA Zacarias","year":"2017","unstructured":"Zacarias DA, Rolao N, de Pinho FA, Sene I, Silva JC, Pereira TC, Costa DL, Costa CHN. Causes and consequences of higher leishmania infantum burden in patients with kala-azar: a study of 625 patients. Trop Med Int Health. 2017;22:679\u201387.","journal-title":"Trop Med Int Health"},{"key":"2691_CR34","doi-asserted-by":"publisher","first-page":"148960","DOI":"10.1016\/j.scitotenv.2021.148960","volume":"797","author":"NNH Valero","year":"2021","unstructured":"Valero NNH, Prist P, Uriarte M. Environmental and socioeconomic risk factors for visceral and cutaneous leishmaniasis in Sao Paulo, Brazil. Sci Total Environ. 2021;797:148960.","journal-title":"Sci Total Environ"},{"key":"2691_CR35","doi-asserted-by":"publisher","first-page":"100185","DOI":"10.1016\/j.crpvbd.2024.100185","volume":"6","author":"D Msellemu","year":"2024","unstructured":"Msellemu D, Tanner M, Yadav R, Moore SJ. Occupational exposure to malaria, leishmaniasis and arbovirus vectors in endemic regions: A systematic review. Curr Res Parasitol Vector Borne Dis. 2024;6:100185.","journal-title":"Curr Res Parasitol Vector Borne Dis"},{"key":"2691_CR36","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1093\/occmed\/kqn131","volume":"58","author":"MC D\u2019Ovidio","year":"2008","unstructured":"D\u2019Ovidio MC, Venturi G, Fiorentini C, Barbati G, Di Renzi S, Vonesch N, Ciufolini MG, Tomao P. Occupational risk associated with Toscana virus infection in Tuscany, Italy. Occup Med (Lond). 2008;58:540\u20134.","journal-title":"Occup Med (Lond)"},{"key":"2691_CR37","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.actatropica.2018.08.033","volume":"188","author":"RT Jones","year":"2018","unstructured":"Jones RT, Tusting LS, Smith HMP, Segbaya S, Macdonald MB, Bangs MJ, Logan JG. The impact of industrial activities on vector-borne disease transmission. Acta Trop. 2018;188:142\u201351.","journal-title":"Acta Trop"},{"key":"2691_CR38","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/S2542-5196(18)30086-X","volume":"2","author":"R Lowe","year":"2018","unstructured":"Lowe R. The impact of global environmental change on vector-borne disease risk: a modelling study. Lancet Planet Health. 2018;2:S1.","journal-title":"Lancet Planet Health"}],"container-title":["International Journal for Equity in Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12939-025-02691-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12939-025-02691-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12939-025-02691-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T12:21:24Z","timestamp":1764073284000},"score":1,"resource":{"primary":{"URL":"https:\/\/equityhealthj.biomedcentral.com\/articles\/10.1186\/s12939-025-02691-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,25]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2691"],"URL":"https:\/\/doi.org\/10.1186\/s12939-025-02691-0","relation":{},"ISSN":["1475-9276"],"issn-type":[{"value":"1475-9276","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,25]]},"assertion":[{"value":"15 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"329"}}